These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2505711)

  • 1. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():31-4. PubMed ID: 2505711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():499-506. PubMed ID: 2605799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
    Tsai HH; Lees KR; Howden CW; Reid JL
    Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perindopril. A review of its pharmacokinetics and clinical pharmacology.
    Macfadyen RJ; Lees KR; Reid JL
    Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of perindopril in patients with liver cirrhosis.
    Thiollet M; Funck-Brentano C; Grangé JD; Midavaine M; Resplandy G; Jaillon P
    Br J Clin Pharmacol; 1992 Mar; 33(3):326-8. PubMed ID: 1576057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
    Verpooten GA; Genissel PM; Thomas JR; De Broe ME
    Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
    Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
    West JN; Smith SA; Stallard TJ; Littler WA
    J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of perindopril in high-risk populations.
    Resplandy G; Genissel P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S9-18. PubMed ID: 1725203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril.
    Louis WJ; Conway EL; Krum H; Workman B; Drummer OH; Lam W; Phillips P; Howes LG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():55-60. PubMed ID: 1327596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state.
    Parker E; Aarons L; Rowland M; Resplandy G
    Eur J Pharm Sci; 2005 Sep; 26(1):104-13. PubMed ID: 15982858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
    Yamada S; Muraoka I; Kato K; Hiromi Y; Takasu R; Seno H; Kawahara H; Nabeshima T
    Biol Pharm Bull; 2003 Jun; 26(6):872-5. PubMed ID: 12808303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.
    Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL; Backhouse CI; Grippat JC; Santoni JP
    Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.